990
Views
16
CrossRef citations to date
0
Altmetric
Author's View

HDAC inhibitors and their potential applications to glioblastoma therapy

&
Article: e25219 | Received 27 May 2013, Accepted 29 May 2013, Published online: 10 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now

Articles from other publishers (14)

Rui Chen, Mengxian Zhang, Yangmei Zhou, Wenjing Guo, Ming Yi, Ziyan Zhang, Yanpeng Ding & Yali Wang. (2020) The application of histone deacetylases inhibitors in glioblastoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Irene Santos-Barriopedro, Yixuan Li, Sonali Bahl & Edward Seto. (2019) HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1. Genes & Cancer 10:5-6, pages 119-133.
Crossref
Aline Menezes, Gustavo Henrique dos Reis, Maria Cecília Oliveira-Nunes, Fernanda Mariath, Mariana Cabanel, Bruno Pontes, Newton Gonçalves Castro, José Marques de Brito & Katia Carneiro. (2019) Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation. Journal of Oncology 2019, pages 1-16.
Crossref
Seung Ah Choi, Chanhee Lee, Pil Ae Kwak, Chul-Kee Park, Kyu-Chang Wang, Ji Hoon Phi, Ji Yeoun Lee, Sangjoon Chong & Seung-Ki Kim. (2019) Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma. Cancer Letters 442, pages 161-169.
Crossref
Bianca Maria Scicchitano, Silvia Sorrentino, Gabriella Proietti, Gina Lama, Gabriella Dobrowolny, Angela Catizone, Elena Binda, Luigi Maria Larocca & Gigliola Sica. (2018) Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Cancer Cell International 18:1.
Crossref
Kyle T. Householder, Danielle M. DiPerna, Eugene P. Chung, Anne Rosa Luning, Duong T. Nguyen, Sarah E. Stabenfeldt, Shwetal Mehta & Rachael W. Sirianni. (2018) pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma. Colloids and Surfaces B: Biointerfaces 166, pages 37-44.
Crossref
Sze Kiat Tan, Anna Jermakowicz, Adnan K. Mookhtiar, Charles B. Nemeroff, Stephan C. Schürer & Nagi G. Ayad. (2018) Drug Repositioning in Glioblastoma: A Pathway Perspective. Frontiers in Pharmacology 9.
Crossref
Xiao-Qiang Wang, Hong-Min Bai, Shi-Ting Li, Hui Sun, Ling-Zhao Min, Bang-Bao Tao, Jun Zhong & Bin Li. (2017) Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cells. Oncotarget 8:29, pages 48027-48040.
Crossref
Seung Ah Choi, Pil Ae Kwak, Chul-Kee Park, Kyu-Chang Wang, Ji Hoon Phi, Ji Yeoun Lee, Chang Sik Lee, Ju-Hee Lee & Seung-Ki Kim. (2016) A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. Oncotarget 8:6, pages 9123-9133.
Crossref
Wallax Augusto Silva Ferreira, Danilo do Rosário Pinheiro, Carlos Antonio da Costa Junior, Symara Rodrigues-Antunes, Mariana Diniz Araújo, Mariceli Baia Leão Barros, Adriana Corrêa de Souza Teixeira, Thamirys Aline Silva Faro, Rommel Rodriguez Burbano, Edivaldo Herculano Correa de Oliveira, Maria Lúcia Harada & Bárbara do Nascimento Borges. (2016) An update on the epigenetics of glioblastomas. Epigenomics 8:9, pages 1289-1305.
Crossref
Qilin Wang, Shangjing Guo & Yaman Gao. (2016) Protein Lysine Acetylated/Deacetylated Enzymes and the Metabolism-Related Diseases. Advances in Bioscience and Biotechnology 07:11, pages 454-467.
Crossref
Shun Li, Xiao Liu, Xiangrong Chen, Liu Zhang & Xiangyu Wang. (2015) Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling. Tumor Biology 36:12, pages 9661-9665.
Crossref
Katalin Eder & Bernadette Kalman. (2015) The Dynamics of Interactions Among Immune and Glioblastoma Cells. NeuroMolecular Medicine 17:4, pages 335-352.
Crossref
Gwyneth Hyman, Vinod Manglik, Jeffrey M. Rousch, Mukesh Verma, David Kinkebiel & Hirendra Nath Banerjee. 2015. Cancer Epigenetics. Cancer Epigenetics 511 521 .